Narrowband UVB phototherapy for clinically isolated syndrome: A trial to deliver the benefits of vitamin D and other UVB-induced molecules

Frontiers in Immunology

Volumn 8, Issue JAN, 2017, Pages

  Hart, Prue H ^a   Lucas, Robyn M ^a,b   Booth, David R ^c   Carroll, William M ^d   Nolan, David ^e,f   Cole, Judith M ^g   Jones, Anderson P ^a   Kermode, Allan G ^d,e  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b The Australian National University   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e MURDOCH UNIVERSITY   (Australia)

^f ROYAL PERTH HOSPITAL   (Australia)

^g St John of God Dermatology   (Australia)

Author keywords

Clinically isolated syndrome; Multiple sclerosis; Narrowband UVB phototherapy; Trial; UV induced immunosuppression; Vitamin D; Vitamin D supplementation

Indexed keywords

CALCIFEDIOL; COD LIVER OIL; VITAMIN D;

ARTICLE; CASE CONTROL STUDY; DEMYELINATING DISEASE; DISEASE ASSESSMENT; DISEASE COURSE; HUMAN; HYPERSENSITIVITY; IMMUNOREGULATION; INTERVENTION STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; ULTRAVIOLET B PHOTOTHERAPY; ULTRAVIOLET PHOTOTHERAPY; VITAMIN SUPPLEMENTATION;

EID: 85012236995     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00003     Document Type: Article

References (61)

1. Ascherio A, Munger KL, Lunemann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol (2012) 8:602-12. doi: 10.1038/nrneurol.2012.198
2. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 45:1353-60. doi:10.1038/ng.2770
3. Dobson R, Giovannoni G, Ramagopalan S. The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J Neurol Neurosurg Psychiatry (2013) 84:427-32. doi:10.1136/jnnp-2012-303934
4. Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol (2011) 11:584-96. doi:10.1038/nri3045
5. Ullrich SE, Byrne SN. The immunologic revolution: photoimmunology. J Invest Dermatol (2012) 132:896-905. doi:10.1038/jid.2011.405
6. Taylor BV, Lucas RM, Dear K, Kilpatrick TJ, Pender MP, van der Mei IA, et al. Latitudinal variation in incidence and type of first central nervous system demyelinating events. Mult Scler (2010) 16:398-405. doi:10.1177/1352458509359724
7. Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, Taylor BV, et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology (2011) 76:540-8. doi:10.1212/WNL.0b013e31820af93d
8. Baarnhielm M, Hedstrom AK, Kockum I, Sundqvist E, Gustafsson SA, Hillert J, et al. Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. Eur J Neurol (2012) 19:955-62. doi:10.1111/j.1468-1331.2011.03650.x
9. Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O'Connor K, et al. Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis. J Neurol Neurosurg Psychiatry (2013) 84:1075-81. doi:10.1136/jnnp-2012-304661
10. Norval M, McLoone P, Lesiak A, Narbutt J. The effect of chronic ultraviolet radiation on the human immune system. Photochem Photobiol (2008) 84:19-28. doi:10.1111/j.1751-1097.2007.00239.x
11. Norval M, Halliday GM. The consequences of UV-induced immunosuppression for human health. Photochem Photobiol (2011) 87:965-77. doi:10.1111/j.1751-1097.2011.00969.x
12. Kelly DA, Young AR, McGregor JM, Seed PT, Potten CS, Walker SL. Sensitivity to sunburn is associated with susceptibility to UVR-induced suppression of cutaneous cell-mediated immunity. J Exp Med (2000) 191:561-6. doi:10.1084/jem.191.3.561
13. Fitzpatrick TB. The validity and practicality of sun reactive skin types I through VI. Arch Dermatol (1988) 124:869-71. doi:10.1001/archderm.1988.01670060015008
14. Schwarz T. 25 Years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cells. Photochem Photobiol (2008) 84:10-8. doi:10.1111/j.1751-1097.2007.00223.x
15. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis. Neurology (2014) 83:278-86. doi:10.1212/WNL.0000000000000560
16. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 69:292-302. doi:10.1002/ana.22366
17. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, et al. Intramuscular interferon beta 1a therapy initiated during a first demyelinating event in multiple sclerosis: CHAMPS Study Group. N Engl J Med (2000) 343:898-904. doi:10.1056/NEJM200009283431301
18. Comi G, Martinelli V, Rodegher M, Moiola L, Bajenaru O, Carra A, et al. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (Pre-CISe study): a randomised, double-blind, placebo-controlled trial. Lancet (2009) 374:1503-11. doi:10.1016/S0140-6736(09)61259-9
19. Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, et al. Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 26(Suppl 3):11-21. doi:10.1111/j.1468-3083.2012.04519.x
20. Paul C, Gallini A, Archier E, Castela E, Devaux S, Aractingi S, et al. Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol (2012) 26(Suppl 3):1-10. doi:10.1111/j.1468-3083.2012.04518.x
21. Ala-Houhala MJ, Vahavihu K, Hasan T, Kautiainen H, Ylianttila L, Viljakainen HT, et al. Comparison of narrowband ultraviolet B exposure and oral vitamin D substitution on serum 25-hydroxyvitamin D concentration. Br J Dermatol (2012) 167:160-4. doi:10.1111/j.1365-2133.2012.10990.x
22. Breuer J, Schwab N, Schneider-Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol (2014) 75:739-58. doi:10.1002/ana.24165
23. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol (2009) 27:485-517. doi:10.1146/annurev.immunol.021908.132710
24. Derakhshandi H, Etemadifar M, Feizi A, Abtahi SH, Minagar A, Abtahi MA, et al. Preventative effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial. Acta Neurol Belg (2013) 113:257-63. doi:10.1007/s13760-012-0166-2
25. Cortese M, Riise T, Bjornevik K, Holmøy T, Kampman MT, Magalhaes S, et al. Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvlMS study. Mult Scler (2015) 21:1856-64. doi:10.1177/1352458515578770
26. CADTH Rapid Response Reports. Vitamin D for the treatment or prevention of multiple sclerosis: a review of the clinical effectiveness. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health (2016).
27. Ganesh A, Apel S, Metz L, Paten S. The case for vitamin D supplementation in multiple sclerosis. Mult Scler Relat Disord (2013) 2:281-306. doi:10.1016/j.msard.2012.12.008
28. James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV. The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis. Mult Scler (2013) 19:1571-9. doi:10.1177/1352458513489756
29. Pozuelo-Moyano B, Benito-Leon J, Mitchell AJ, Hernandez-Gallego J. A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis. Neuroepidemiology (2013) 40:147-53. doi:10.1159/000345122
30. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol (2014) 2:76-89. doi:10.1016/S2213-8587(14)70049-X
31. Golan D, Halhal B, Glass-Marmor L, Staun-Ram E, Rozenberg O, Lavi I, et al. Vitamin D supplementation for patients with multiple sclerosis treated with interferon beta: a randomized controlled trial assessing the effect of flu-like symptoms and immunomodulatory properties. BMC Neurol (2013) 13:60. doi:10.1186/1471-2377-13-60
32. Aivo J, Hanninen A, Ilonen J, Soilu-Hanninen M. Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta. J Neuroimmunol (2015) 280:12-5. doi:10.1016/j.jneuroim.2015.01.005
33. Ashtari F, Toghianifar N, Zarkesh-Esfahani SH, Mansourian M. Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. Neuroimmunomodulation (2015) 22:400-4. doi:10.1159/000439278
34. Etemadifar M, Janghorbani M. Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: preliminary findings of a randomized control trial. Iran J Neurol (2015) 14:67-73.
35. Rosjo E, Steffensen LH, Jorgensen L, Lindstrøm JC, Šaltyte Benth J, Michelsen AE, et al. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis. J Neurol (2015) 262:2713-21. doi:10.1007/s00415-015-7902-5
36. Toghianifar N, Ashtari F, Zarkesh-Esfahani SH, Mansourian M. Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. J Neuroimmunol (2015) 285:125-8. doi:10.1016/j.jneuroim.2015.05.022
37. Sotirchos ES, Bhargava P, Eckstein C, Van Haren K, Baynes M, Ntranos A, et al. Safety and immunologic effects of high-versus low-dose cholecalciferol in multiple sclerosis. Neurology (2016) 86:382-90. doi:10.1212/WNL.0000000000002316
38. Jelinek GA, Marck CH, Weiland TJ, Pereira N, van der Meer DM, Hadgkiss EJ. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis. BMC Neurol (2015) 15:132. doi:10.1186/s12883-015-0394-1
39. Najafipoor A, Roghanian R, Zarkesh-Esfahani SH, Bouzari M, Etemadifar M. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients. Cell Immunol (2015) 294:9-12. doi:10.1016/j.cellimm.2015.01.009
40. Bhargava P, Steele SU, Waubant E, Revirajan NR, Marcus J, Dembele M, et al. Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls. Mult Scler (2016) 22:753-60. doi:10.1177/1352458515600248
41. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 29:726-76. doi:10.1210/er.2008-0004
42. Lucas RM, Byrne SN, Correale J, Ilschner S, Hart PH. Ultraviolet radiation, vitamin D and multiple sclerosis. Neurodegener Dis Manag (2015) 5:413-24. doi:10.2217/nmt.15.33
43. Lucas RM, Gorman S, Geldenhuys S, Hart PH. Vitamin D and immunity. F1000Prime Rep (2014) 6:118. doi:10.12703/P6-118
44. Ferreira GB, Vanherwegen A-S, Eelen G, Gutierrez ACF, Van Lommel L, Marchal K, et al. Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways. Cell Rep (2015) 10:711-25. doi:10.1016/j.celrep.2015.01.013
45. Chambers ES, Hawrylowicz CM. The impact of vitamin D on regulatory T cells. Curr Allergy Asthma Rep (2011) 11:29-36. doi:10.1007/s11882-010-0161-8
46. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signalling and activation of human T cells. Nat Immunol (2010) 11:344-9. doi:10.1038/ni.1851
47. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol (2014) 2:307-20. doi:10.1016/S2213-8587(13)70212-2
48. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ (2014) 348:g2035. doi:10.1136/bmj.g2035
49. Mowry EM, Pelletier D, Gao Z, Howell MD, Zamvil SS, Waubant E. Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection. Eur J Neurol (2016) 23:327-32. doi:10.1111/ene.12844
50. Hart PH, Lucas RM, Walsh JP, Zosky GR, Whitehouse AJ, Zhu K, et al. Vitamin D in fetal development: findings from a birth cohort study. Pediatrics (2015) 135:e167-73. doi:10.1542/peds.2014-1860
51. Taguchi K, Fukunaga A, Ogura K, Nishigori C. The role of epidermal Langerhans cells in NB-UVB-induced immunosuppression. Kobe J Med Sci (2013) 59:E1-9.
52. Hancock REW, Haney EF, Gill EE. The immunology of host defence peptides: beyond antimicrobial activity. Nat Rev Immunol (2016) 16:321-34. doi:10.1038/nri.2016.29
53. Cela EM, Friedrich A, Paz ML, Vanzulli SI, Keoni J, Gonzalez Maglio DH. Time-course study of different innate immune mediators produced by UV-irradiated skin: comparative effects of short and daily versus a single harmful UV exposure. Immunology (2014) 145:82-93. doi:10.1111/imm.12427
54. Bruhs A, Schwarz T, Schwarz A. Prevention and mitigation of experimental autoimmune encephalomyelitis by murine b-defensins via induction of regulatory T cells. J Invest Dermatol (2016) 136:173-81. doi:10.1038/JID.2015.405
55. Kok LF, Marsh-Wakefield F, Marshall JE, Gillis C, Halliday GM, Byrne SN. B cells are required for sunlight protection of mice from a CNS-targeted autoimmune attack. J Autoimmun (2016) 73:10-23. doi:10.1016/j.jaut.2016.05.016
56. Schweintzger N, Gruber-Wackernagel A, Reginato E, Bambath I, Quehenberger F, Byrne SN, et al. Levels and function of regulatory T cells in patients with polymorphic light eruption: relation to photohardening. Br J Dermatol (2015) 173:519-26. doi:10.1111/bjd.13930
57. Ng RL, Bisley JL, Gorman S, Norval M, Hart PH. UV-irradiation of mice reduces the competency of bone marrow-derived CD11c+ cells via an indomethacin-inhibitable pathway. J Immunol (2010) 185:7207-15. doi:10.4049/jimmunol.1001693
58. Ng RL, Scott NM, Bisley JL, Lambert MJ, Gorman S, Norval M, et al. Characterisation of regulatory dendritic cells differentiated from the bone marrow of UV-irradiated mice. Immunology (2013) 140:399-412. doi:10.1111/imm.12145
59. Ng RL, Scott NM, Strickland DH, Gorman S, Grimbaldeston MA, Norval M, et al. Altered immunity and dendritic cell activity in the periphery of mice after long-term engraftment with bone marrow from UV-irradiated mice. J Immunol (2013) 190:5471-84. doi:10.4049/jimmunol.1202786
60. Scott NM, Ng RL, Gorman S, Norval M, Waithman J, Hart PH. Prostaglandin E2 imprints a long-lasting effect on dendritic cell progenitors in the bone marrow. J Leukoc Biol (2014) 95:225-32. doi:10.1189/jlb.0513294
61. Felton S, Navid AF, Schwarz A, Schwarz T, Glaser R, Rhodes LE. Ultraviolet radiation-induced upregulation of antimicrobial proteins in health and disease. Photochem Photobiol Sci (2013) 12:29-36. doi:10.1039/c2pp25158b